Curelab Veterinary

Curelab Veterinary operates as an animal-health company that specializes in treating breast cancer in dogs and cats.

CureLab Veterinary is a biotech company dedicated to bringing advanced therapies to treat cancer and inflammatory diseases in pets. The company's lead product, ElenaVet, is a patented DNA plasmid encoding the p62/SQSTM1 gene. In clinical trials, ElenaVet demonstrated promising results in treating breast cancer, successfully helping 10 out of 11 dogs diagnosed with the disease. The company plans to leverage this technology to treat other types of cancers as well as conditions like osteoarthritis and inflammatory bowel syndrome, which are prevalent among elderly dogs and cats. ElenaVet works by reversing tumor grade, altering the tumor microenvironment, enhancing the effects of chemotherapy, mitigating chronic inflammation, and stimulating an immune response against tumors. CureLab Veterinary has a comprehensive patent portfolio covering its technology in over 20 countries. In January 2023, the company launched an equity crowdfunding campaign to raise funds for the USDA-CVB approval process and production of ElenaVet in the US.

CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne

Curelab Veterinary Launches in Animal Health Sector, Leveraging Technology Licensed from CureLab Oncology

CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses

CureLab Veterinary Launches Equity Crowdfunding Campaign on Wefunder to Revolutionize Medicine for Dogs, Cats, and Horses

Promoting the health, well-being, and ethical treatment of animals

Animal Therapeutics

CureLab Veterinary is a biotech company dedicated to bringing advanced therapies to treat cancer and inflammatory diseases in pets. The company's lead product, ElenaVet, is a patented DNA plasmid encoding the p62/SQSTM1 gene. In clinical trials, ElenaVet demonstrated promising results in treating breast cancer, successfully helping 10 out of 11 dogs diagnosed with the disease. The company plans to leverage this technology to treat other types of cancers as well as conditions like osteoarthritis and inflammatory bowel syndrome, which are prevalent among elderly dogs and cats. ElenaVet works by reversing tumor grade, altering the tumor microenvironment, enhancing the effects of chemotherapy, mitigating chronic inflammation, and stimulating an immune response against tumors. CureLab Veterinary has a comprehensive patent portfolio covering its technology in over 20 countries. In January 2023, the company launched an equity crowdfunding campaign to raise funds for the USDA-CVB approval process and production of ElenaVet in the US.
CureLab Veterinary is a sister company of CureLab Oncology, which is developing a similar DNA plasmid therapy called Elenagen for human cancers. The research activities of the two companies are highly synergistic, with data from veterinary applications informing the human clinical trials. In March 2023, CureLab Oncology and CureLab Veterinary received a USD 3 million investment from Dr. John Ballantyne, a prominent biotech investor and former chief scientific officer of Aldevron, a leading manufacturer of plasmids.

KeraVet Bio is a veterinary wound care company that develops keratin-based prescription products for dogs and cats. The company's flagship product, KeraVet Gel, is a wound management solution formulated to address mild and severe wounds, post-surgical incisions, and various dermatological conditions in pets. KeraVet Gel is made from a proprietary blend of keratin and utilizes patent-protected keratin technology. The product serves as a protective covering over wounds and is designed to improve healing time while reducing the need for cones or other lick deterrents. Clinical studies have shown that wounds treated with KeraVet Gel experienced significantly less swelling compared to those treated with triple antibiotic ointment in dogs and cats. The gel also demonstrated a reduction in licking behavior, with dogs licking 85% less and cats licking 87% less compared to a well-known wound management product. KeraVet Gel is available by prescription from veterinary practitioners and is distributed through major veterinary product distributors. The company is headquartered in the Innovation Quarter in Winston-Salem, North Carolina.

KeraVet Bio

Eir Pharmaceuticals was a development-stage biotechnology company that operated in multiple markets, including animal health, human consumer, and human health. The company's proprietary biotechnology platform was designed to develop and commercialize health, wellness, and pharmaceutical products across these diverse sectors. Eir Pharmaceuticals aimed to leverage its technology to capture value from various applications and target different customer segments within the broader healthcare industry.

EIR Pharmaceuticals

ProteaPex Therapeutics is a biotechnology company focused on developing therapies and dietary supplements for osteoarthritis. Their key product offering is ECPF-1, a novel therapeutic compound that has demonstrated chondroprotective properties in a rat model of osteoarthritis. In October 2023, the company presented findings from a study where ECPF-1 was administered through weekly injections to rats with osteoarthritis. The results showed that the knee cartilage of treated animals had less degradation and more healthy cartilage compared to untreated controls, even four weeks after the last injection. This suggests that ECPF-1 has the potential to slow the progression of osteoarthritis by protecting cartilage from further damage.
ProteaPex Therapeutics' platform technology revolves around Extracellular Matrix Protection Factors (ECPFs), a class of compounds derived from their research on cartilage biology and chondrocyte differentiation. In addition to ECPF-1, the company is also developing dietary supplement products based on this platform.

ProteaPex Therapeutics

MedcoVet offers a patented at-home laser therapy treatment device for pets suffering from arthritis, pain, and other inflammatory conditions. The company's technology allows veterinarians to prescribe clinical laser therapy for their patients to be administered in the comfort of their homes. MedcoVet's devices utilize photobiomodulation, a scientifically proven technique that relieves pain and expedites healing in animals.
The company partners with veterinarians, shipping the treatment devices directly to pet owners while providing telemedicine support to ensure proper usage. This approach enables veterinarians to offer laser therapy as a primary treatment modality without the inconvenience and expenses associated with in-clinic sessions. As of 2023, MedcoVet had 77 prescribers across 13 states in the US, experiencing a 50% quarter-on-quarter growth in prescribers during the previous quarter.
Several veterinary professionals and pet owners have reported significant improvements in their patients' mobility, reduced swelling and discomfort, and the ability to lower medication doses after using MedcoVet's at-home laser therapy devices. The company's technology has been praised for revolutionizing the application of laser therapy in veterinary medicine, making it more accessible and convenient for pet owners.

MedcoVet

Hilltop BioSciences, co-founded by Amanda Drobnis, is a veterinary biotech company pioneering the development of innovative regenerative therapies. Their flagship product, Regenaflex, is a room temperature, easy-to-use regenerative allograft available in injectable or membrane form. It stimulates cell-to-cell communication essential for healing soft tissue by delivering a potent combination of cytokines, microRNA, growth factors, and exosomes to the affected area. Regenaflex accelerates tissue healing, reduces inflammation, and minimizes scar tissue formation, making it a more effective and faster therapy compared to traditional treatments.
Initially focused on equine applications, with over 7 million horses in the US, Hilltop BioSciences has expanded into the companion animal market. Their product line includes Regenaflex-K9 for treating acute trauma, chronic infections, inflammation, non-healing wounds, anal gland abscesses, and fistulae in dogs. Regenaflex-M Biofilm is an anti-inflammatory, antimicrobial, and anti-adhesion scaffold that accelerates healing and prevents postoperative complications like adhesions and suture leakage after abdominal or orthopedic surgeries. PureOptic, their eye drop formulation, normalizes damaged ocular tissue resulting from injuries or diseases.
A key differentiator of Hilltop Bio's products is their long-term room-temperature storage, consistent composition in every dose, and the ability to be reconstituted and ready to use within a minute without any special equipment or time-consuming processing. As of January 2023, the company had raised funding led by Launchpad Venture Group and other Boston-based investment groups to expand its product pipeline leveraging its intellectual property portfolio.

Hilltop BioSciences

Companies that offer specialized therapeutics for the diagnosis, treatment, and management of cancer in animals. This includes areas such as cancer diagnosis, surgery, chemotherapy, and immunotherapy.

Companies that develop vaccines and drugs for pets and livestock based on advanced research and biotechnologies such as DNA technology, with a specific focus on the treatment and prevention of diseases and medical conditions in animals.

Companies that use regenerative techniques and technologies to promote tissue repair, regeneration, and healing in animals. This involves stem cell therapy, platelet-rich plasma (PRP) therapy, tissue engineering, gene therapy, and wound healing treatments.

Companies that provide veterinary diagnostic services, which include a wide range of tests, procedures, and laboratory services to diagnose, monitor, and manage the health and well-being of animals. This includes laboratory testing, diagnostic imaging, endoscopy, and genetic testing.

Companies that provide specialized treatments aimed at extending the lifespan and improving the overall health and quality of life of animals, including companion animals and livestock. These approaches are designed to address the challenges of aging, prevent age-related diseases, and enhance the well-being of aging animals.

Offers advanced diagnostics and insights for animal health using AI/ML

Offers products and services specifically designed for diagnostics and treatments based on advanced genomic sciences

Offers personalized preventive care and specialty care for animals

Curelab Veterinary

Sources

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless